Video

Impact of Long-Acting HIV Prevention Drugs

A panel of experts discuss the role of PrEP in HIV prevention with a focus on current and newly approved options.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
5 experts in this video
1 expert is featured in this series.
5 experts in this video
5 experts in this video
1 expert is featured in this series.
1 expert is featured in this series.
5 experts in this video
5 experts in this video
1 expert is featured in this series.
1 expert is featured in this series.
Related Content
Pharmacist-Led HCV Program Uncovers Syndemic Risks, Supports Expanded Screening
June 10th 2025

Pharmacist-Led HCV Program Uncovers Syndemic Risks, Supports Expanded Screening

Aislinn Antrim, Managing Editor
Public Health Matters: Walmart is Elevating Specialty Pharmacy Services and Enriching HIV Care
July 25th 2024

Public Health Matters: Walmart is Elevating Specialty Pharmacy Services and Enriching HIV Care

Herpes Zoster as an Early Indicator of HIV: Clinical Insights
March 31st 2025

Herpes Zoster as an Early Indicator of HIV: Clinical Insights

Emilia Welch, PharmD, MBA
Public Health Matters: The Pharmacist's Role in the HIV Space, Removing Barriers, Racial Disparities
February 7th 2024

Public Health Matters: The Pharmacist's Role in the HIV Space, Removing Barriers, Racial Disparities

HIV virus cells. Scientifically accurate human immunodeficiency virus (HIV) close-up view. Acquired immunodeficiency syndrome AIDS 3D medical illustration.
March 19th 2025

New Data on HIV-1 Treatments, Including Biktarvy and Novel Lenacapavir Combination Regimen, Presented at CROI 2025

Luke Halpern, Assistant Editor
Positive HIV blood test -- Image credit: jarun011 | stock.adobe.com
March 17th 2025

CROI 2025: Key Updates on ViiV Healthcare’s Cabenuva and Apretude

Gillian McGovern, Associate Editor